{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T01:10:12Z","timestamp":1770253812336,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["72274037"],"award-info":[{"award-number":["72274037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"DOI":"10.1186\/s13690-025-01825-8","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:37:04Z","timestamp":1767843424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparing disease burden of rare diseases with common medical conditions in china: evidence from a national online health survey in 2022"],"prefix":"10.1186","volume":"84","author":[{"given":"Xinyi","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"6","key":"1825_CR1","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jval.2015.05.008","volume":"18","author":"T Richter","year":"2015","unstructured":"Richter T, Nestler-Parr S, Babela R, Khan ZM, Tesoro T, Molsen E, et al. Rare disease terminology and Definitions-A systematic global review: report of the ISPOR rare disease special interest group. Value Health. 2015;18(6):906\u201314.","journal-title":"Value Health"},{"issue":"1","key":"1825_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5582\/irdr.2022.01034","volume":"11","author":"YQ Lu","year":"2022","unstructured":"Lu YQ, Han JX. The definition of rare disease in China and its prospects. Intractable Rare Dis. 2022;11(1):29\u201330.","journal-title":"Intractable Rare Dis"},{"key":"1825_CR3","doi-asserted-by":"crossref","unstructured":"Liu ML, Lu YQ, Li JF, Zhang YT, Zhang SS, Liu YS. Orphan drug policy analysis in China. Front Pharmacol. 2024;15.","DOI":"10.3389\/fphar.2024.1278710"},{"issue":"7","key":"1825_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11427-017-9100-1","volume":"60","author":"X Ni","year":"2017","unstructured":"Ni X, Shi TL. The challenge and promise of rare disease diagnosis in China. Sci China Life Sci. 2017;60(7):681\u20135.","journal-title":"Sci China Life Sci"},{"key":"1825_CR5","doi-asserted-by":"crossref","unstructured":"Adachi T, El-Hattab AW, Jain R, Nogales Crespo KA, Quirland Lazo CI, Scarpa M, et al. Enhancing equitable access to rare disease diagnosis and treatment around the world: A review of Evidence, Policies, and challenges. Int J Environ Res Public Health. 2023;20(6):1\u201337.","DOI":"10.3390\/ijerph20064732"},{"issue":"1","key":"1825_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jphys.2022.06.008","volume":"69","author":"S De Silva","year":"2023","unstructured":"De Silva S, Higgins AM, Clinimetrics. The quality adjusted life year. J Physiother. 2023;69(1):58\u20139.","journal-title":"J Physiother"},{"key":"1825_CR7","doi-asserted-by":"crossref","unstructured":"Toure M, Kouakou CRC, Poder TG. Dimensions used in instruments for QALY calculation: A systematic review. Int J Environ Res Public Health. 2021;18(9):4428.","DOI":"10.3390\/ijerph18094428"},{"issue":"Suppl 5","key":"1825_CR8","first-page":"S43","volume":"97","author":"M Thavorncharoensap","year":"2014","unstructured":"Thavorncharoensap M. Measurement of utility. J Med Assoc Thai. 2014;97(Suppl 5):S43\u20139.","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"1825_CR9","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1186\/s12889-022-13675-y","volume":"22","author":"L Van Wilder","year":"2022","unstructured":"Van Wilder L, Devleesschauwer B, Clays E, Van der Heyden J, Charafeddine R, Scohy A, et al. QALY losses for chronic diseases and its social distribution in the general population: results from the Belgian health interview survey. BMC Public Health. 2022;22(1):1304.","journal-title":"BMC Public Health"},{"key":"1825_CR10","doi-asserted-by":"publisher","first-page":"104626","DOI":"10.1016\/j.msard.2023.104626","volume":"73","author":"Q Jiang","year":"2023","unstructured":"Jiang Q, Wang W, Chen W, Xu Y. The impact of cognitive impairment on disease burden in Chinese patients with multiple sclerosis: A model simulation study. Mult Scler Relat Disord. 2023;73:104626.","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"1825_CR11","doi-asserted-by":"publisher","first-page":"13562","DOI":"10.1038\/s41598-022-17942-1","volume":"12","author":"K Kucnerowicz","year":"2022","unstructured":"Kucnerowicz K, Pietrzak A, Cholewinski W, Martenka P, Marszalek A, Burchardt E, et al. The quality-adjusted life-years in the oncological patients\u2019 health-related quality of life. Sci Rep. 2022;12(1):13562.","journal-title":"Sci Rep"},{"key":"1825_CR12","doi-asserted-by":"publisher","first-page":"e2012008","DOI":"10.4178\/epih\/e2012008","volume":"34","author":"SE Chung","year":"2012","unstructured":"Chung SE, Cheong HK, Park JH, Kim HJ. Burden of disease of multiple sclerosis in Korea. Epidemiol Health. 2012;34:e2012008.","journal-title":"Epidemiol Health"},{"issue":"6","key":"1825_CR13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/14737167.2023.2206569","volume":"23","author":"Y Gil-Rojas","year":"2023","unstructured":"Gil-Rojas Y, Su\u00e1rez-Obando F, Amaya-Granados D, Prieto-Pinto L, Samac\u00e1-Samac\u00e1 D, Ortiz B, et al. Burden of disease of spinal muscular atrophy linked to chromosome 5q (5q-SMA) in Colombia. Expert Rev Pharmacoecon Outcomes Res. 2023;23(6):671\u201382.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"12","key":"1825_CR14","doi-asserted-by":"publisher","first-page":"e066335","DOI":"10.1136\/bmjopen-2022-066335","volume":"12","author":"M Li","year":"2022","unstructured":"Li M, Zhou N, Duan S, Zhong H, Jiang R, Yuan N. Burden and trends of multiple sclerosis in China from 1990 to 2019: a systematic analysis for the global burden of disease study 2019. BMJ Open. 2022;12(12):e066335.","journal-title":"BMJ Open"},{"key":"1825_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.53388\/202219","volume":"4","author":"Y Wang","year":"2022","unstructured":"Wang Y, Kaierdebieke A, Fan S, Zhang R, Huang M, Li H, et al. Study protocol: A cross-sectional study on psychology and behavior investigation of Chinese residents, PBICR. Psychosom Med Res. 2022;4:13\u20139.","journal-title":"Psychosom Med Res"},{"key":"1825_CR16","unstructured":"China NHCotPsRo. Notice on the publication of the first list of rare diseases: The State Council of the People\u2019s Republic of China. 2018 [Available from: https:\/\/www.gov.cn\/zhengce\/zhengceku\/2018-12\/31\/content_5435167.htm"},{"issue":"1","key":"1825_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12939-023-01910-w","volume":"22","author":"L Xue","year":"2023","unstructured":"Xue L, Cai M, Liu Q, Ying X, Wu S. Trends and regional variations in chronic diseases and their risk factors in china: an observational study based on National health service surveys. Int J Equity Health. 2023;22(1):120.","journal-title":"Int J Equity Health"},{"key":"1825_CR18","doi-asserted-by":"crossref","unstructured":"Wang H, Xu Z, Chen DD, Li HH, Zhang JY, Liu QH, et al. Prevalence and causes of blindness and distance visual impairment in Chinese adult population in 2022 during the COVID-19 pandemic: a cross-sectional study. Sci Rep-Uk. 2024;14:3890.","DOI":"10.1038\/s41598-024-54325-0"},{"key":"1825_CR19","doi-asserted-by":"crossref","unstructured":"Zou MJ, Guo DW, Chen AM, Young CA, Li Y, Zheng DY, et al. Prevalence of visual impairment among older Chinese population: A systematic review and meta-analysis. J Glob Health. 2021;11:08004.","DOI":"10.7189\/jogh.11.08004"},{"issue":"3","key":"1825_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/jgh.15751","volume":"37","author":"S Ren","year":"2022","unstructured":"Ren S, Cai P, Liu Y, Wang T, Zhang Y, Li Q, et al. Prevalence of Helicobacter pylori infection in china: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2022;37(3):464\u201370.","journal-title":"J Gastroenterol Hepatol"},{"issue":"16","key":"1825_CR21","doi-asserted-by":"publisher","first-page":"11917","DOI":"10.18632\/aging.206065","volume":"16","author":"W Zhao","year":"2024","unstructured":"Zhao W, Han Y, Xiao Y, Liu Y, Zhang Z, Liao L, et al. Relationship between Helicobacter pylori infection and digestive tract diseases and analysis of risk factors: a cross-sectional study based on 3867 Chinese patients. Aging. 2024;16(16):11917\u201325.","journal-title":"Aging"},{"issue":"52","key":"1825_CR22","doi-asserted-by":"publisher","first-page":"e9507","DOI":"10.1097\/MD.0000000000009507","volume":"96","author":"H Taguchi","year":"2017","unstructured":"Taguchi H, Kanmura S, Maeda T, Iwaya H, Arima S, Sasaki F, et al. Helicobacter pylori eradication improves the quality of life regardless of the treatment outcome: A multicenter prospective cohort study. Med (Baltim). 2017;96(52):e9507.","journal-title":"Med (Baltim)"},{"issue":"10","key":"1825_CR23","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"4","key":"1825_CR24","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","volume":"20","author":"N Luo","year":"2017","unstructured":"Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L value set for China. Value Health. 2017;20(4):662\u20139.","journal-title":"Value Health"},{"issue":"7","key":"1825_CR25","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1001\/jamaophthalmol.2016.1158","volume":"134","author":"SJ Park","year":"2016","unstructured":"Park SJ, Ahn S, Park KH. Burden of visual impairment and chronic diseases. Jama Ophthalmol. 2016;134(7):778\u201384.","journal-title":"Jama Ophthalmol"},{"key":"1825_CR26","doi-asserted-by":"crossref","unstructured":"Van Wilder L, Devleesschauwer B, Clays E, Van der Heyden J, Charafeddine R, Scohy A, et al. QALY losses for chronic diseases and its social distribution in the general population: results from the Belgian health interview survey. BMC Public Health. 2022;22(1):1304.","DOI":"10.1186\/s12889-022-13675-y"},{"key":"1825_CR27","doi-asserted-by":"crossref","unstructured":"Dong D, Chung RYN, Chan RHW, Gong SW, Xu RH. Why is misdiagnosis more likely among some people with rare diseases than others? Insights from a population-based cross-sectional study in China. Orphanet J Rare Dis. 2020;15(1):307.","DOI":"10.1186\/s13023-020-01587-2"},{"key":"1825_CR28","doi-asserted-by":"crossref","unstructured":"Chiu ATG, Chung CCY, Wong WHS, Lee SL, Chung BHY. Healthcare burden of rare diseases in Hong Kong - adopting orphacodes in ICD-10 based healthcare administrative datasets. Orphanet J Rare Dis. 2018;13(1):147.","DOI":"10.1186\/s13023-018-0892-5"},{"issue":"5","key":"1825_CR29","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/gutjnl-2022-328965","volume":"72","author":"XZ Zhou","year":"2023","unstructured":"Zhou XZ, Lyu NH, Zhu HY, Cai QC, Kong XY, Xie P, et al. Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in china: the time to change practice for related disease prevention. Gut. 2023;72(5):855\u201369.","journal-title":"Gut"},{"key":"1825_CR30","doi-asserted-by":"crossref","unstructured":"Xu RH, Ng SSM, Luo N, Dong D, Zhang SY. Measurement of Health-Related quality of life in individuals with rare diseases in china: Nation-Wide online survey. Jmir Public Health Surveillance. 2023;9:e50147.","DOI":"10.2196\/50147"},{"issue":"9","key":"1825_CR31","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.jval.2022.04.1725","volume":"25","author":"YNC Ng","year":"2022","unstructured":"Ng YNC, Ng NYT, Fung JLF, Lui ACY, Cheung NYC, Wong WHS, et al. Evaluating the Health-Related quality of life of the rare disease population in Hong Kong using EQ-5D 3-Level. Value Health. 2022;25(9):1624\u201333.","journal-title":"Value Health"},{"key":"1825_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jpsychires.2022.03.042","volume":"150","author":"S Chen","year":"2022","unstructured":"Chen S, Wang Y, Zhu L, Feng Z, Gong S, Dong D. Social activity as mediator between social support and psychological quality of life among people with rare diseases: A National repetitive cross-sectional study. J Psychiatr Res. 2022;150:147\u201352.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1825_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13023-018-0810-x","volume":"13","author":"A Slade","year":"2018","unstructured":"Slade A, Isa F, Kyte D, Pankhurst T, Kerecuk L, Ferguson J, et al. Patient reported outcome measures in rare diseases: a narrative review. Orphanet J Rare Dis. 2018;13(1):61.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1825_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s41687-021-00336-8","volume":"5","author":"WR Lenderking","year":"2021","unstructured":"Lenderking WR, Anatchkova M, Pokrzywinski R, Skalicky A, Martin ML, Gelhorn H. Measuring health-related quality of life in patients with rare disease. J Patient Rep Outcomes. 2021;5(1):61.","journal-title":"J Patient Rep Outcomes"},{"key":"1825_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13023-016-0409-z","volume":"11","author":"C Molster","year":"2016","unstructured":"Molster C, Urwin D, Di Pietro L, Fookes M, Petrie D, van der Laan S, et al. Survey of healthcare experiences of Australian adults living with rare diseases. Orphanet J Rare Dis. 2016;11:30.","journal-title":"Orphanet J Rare Dis"},{"key":"1825_CR36","doi-asserted-by":"crossref","unstructured":"Whicher D, Philbin S, Aronson N. An overview of the impact of rare disease characteristics on research methodology. Orphanet J Rare Dis. 2018;13(1):14.","DOI":"10.1186\/s13023-017-0755-5"},{"issue":"1","key":"1825_CR37","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12888-021-03428-3","volume":"21","author":"Y Ma","year":"2021","unstructured":"Ma Y, Xiang Q, Yan C, Liao H, Wang J. Relationship between chronic diseases and depression: the mediating effect of pain. BMC Psychiatry. 2021;21(1):436.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"1825_CR38","first-page":"283","volume":"31","author":"MC Hornbrook","year":"1996","unstructured":"Hornbrook MC, Goodman MJ. Chronic disease, functional health status, and demographics: a multi-dimensional approach to risk adjustment. Health Serv Res. 1996;31(3):283\u2013307.","journal-title":"Health Serv Res"},{"issue":"9859","key":"1825_CR39","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2163\u201396.","journal-title":"Lancet"},{"issue":"7","key":"1825_CR40","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.healthpol.2014.12.016","volume":"119","author":"A Angelis","year":"2015","unstructured":"Angelis A, Tordrup D, Kanavos P. Socio-economic burden of rare diseases: A systematic review of cost of illness evidence. Health Policy. 2015;119(7):964\u201379.","journal-title":"Health Policy"}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-025-01825-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-025-01825-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-025-01825-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:50:38Z","timestamp":1770205838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13690-025-01825-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1825"],"URL":"https:\/\/doi.org\/10.1186\/s13690-025-01825-8","relation":{},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Research Committee approved the current study (No. JKWH-2022\u201302, No.2022-K050). Informed consent was obtained from all participants involved in the study. In addition to this, we confirm that all methods were performed in accordance with the relevant guidelines and regulations.All participants provided voluntary informed consent to participate in this study, and they were assured of the confidentiality and anonymity of their responses. Informed consent was obtained from each participant before they began the survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants in this study agreed to data being used for publications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}